PDA, ISPE Release Statement Confirming Commitment to Pharmaceutical Science and Engineering

BETHESDA, Md., Oct. 25, 2017 /PRNewswire-USNewswire/ -- The Parenteral Drug Association (PDA) and the International Society of Pharmaceutical Engineers (ISPE) today released a joint statement confirming their combined commitment to fulfilling their respective missions and guiding their members and stakeholders toward using the best science and engineering to continue to provide high-quality, safe, and effective medicines to serve patients. The two not-for-profit membership associations also affirmed their commitment to continuing our collaborations that provide unbiased platforms for dialogue to benefit the global pharmaceutical and biopharmaceutical community.

The pharmaceutical and biopharmaceutical community faces many challenges in our changing global environment. New technologies are required for manufacturing and control of a more diverse product portfolio; new techniques are needed for managing a global supply chain; and regular information is needed about the changing regulatory landscape. 

Fortunately, there are non-profit organizations that work through their members to educate our industry, and also work together to define and disseminate consensus guidance and best practices.  Non-profit organizations fund these activities through membership dues, publication sales, and, in large part, through registration fees from education conferences and training courses.  We pride ourselves on providing neutral, high-quality, and reliable information to our members and attendees.

Today, we see an increasing number of for-profit conference organizers who duplicate the content developed by non-profit organizations, employ aggressive marketing techniques, and charge high prices for that content. This siphons much needed support from non-profit organizations such as ours.

As leaders of two global member-driven organizations, ISPE and PDA, with nearly 30,000 members between us, we value the support that the community gives us.  We are committed to fulfilling our missions, to guide our members and stakeholders towards using the best science and engineering to continue to provide high-quality, safe, and effective medicines to serve patients.

Furthermore, we are committed to continuing our collaborations that provide unbiased platforms for dialogue, such as in cross-industry initiatives and inter-association groups, among others, that benefit the global pharmaceutical and biopharmaceutical community.

Richard Johnson   
President and CEO         
Parenteral Drug Association (PDA) 

John Bournas                                           
President and CEO                                                      
International Society for Pharmaceutical Engineering (ISPE)                                                                           

About PDA – Connecting People, Science and Regulation®

The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its 10,000 members worldwide. Go to http://www.pda.org/footer/about-pda to learn more.

Media Inquiries: Walt Morris, 301-656-5900, x. 148; [email protected]

SOURCE Parenteral Drug Association

Related Links

http://www.pda.org